Clinical Trials Logo

Decidual Stromal Cells clinical trials

View clinical trials related to Decidual Stromal Cells.

Filter by:
  • None
  • Page 1

NCT ID: NCT02175303 Recruiting - Inflammation Clinical Trials

A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting

Start date: December 2013
Phase: Phase 1/Phase 2
Study type: Interventional

To evaluate safety and efficacy using decidual stromal cell therapy for toxicity and inflammation, with special focus on allogeneic hematopoietic cell transplantation patients. The hypothesis to be tested is that the cells are safe to infuse and that they have an anti-inflammatory and healing effect.

NCT ID: NCT02174536 Recruiting - Clinical trials for Stem Cell Transplantation

A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis

Start date: March 2014
Phase: Phase 2
Study type: Interventional

A prospective double blind randomized study comparing placenta derived decidual stromal cells with placebo for hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. It is hypothesized that the decidual stromal cell therapy will be superior to placebo.